CBD and Drug Interactions: What You Need to Know Before Starting
Affiliate Disclosure: This post may contain affiliate links. We may earn a commission if you purchase through our links at...
Read moreIrritable bowel syndrome (IBS) affects millions and involves gut dysregulation, visceral sensitivity, and inflammation. The endocannabinoid system regulates gut motility and barrier function. Research suggests CBD may help reduce gut inflammation, calm intestinal spasms, and improve gut-brain signaling. For IBS-D (diarrhea-predominant), IBS-C (constipation-predominant), or IBS-M (mixed), CBD works differently depending on the subtype.
Start with 5-10mg of CBD daily and increase to 15-25mg based on response. For IBS-D, take CBD 30-60 minutes before meals to reduce cramping. For IBS-C, evening dosing may help normalize bowel function. Timing matters—consistent daily use is more effective than sporadic dosing. Monitor for any changes in bowel habits during the first 2-3 weeks.
Softgels and tinctures offer precise dosing for IBS management. Enteric-coated options bypass stomach acid and release CBD in the intestines for targeted benefit. Full-spectrum formulas may offer additional gut-supporting terpenes. Avoid high-fat CBD products if you have fat-sensitivity IBS, and choose products with third-party COA verification.
Combine CBD with proven IBS management techniques: low-FODMAP diet, stress reduction, regular exercise, and adequate sleep. CBD works best as part of a comprehensive approach. Keep a symptom diary to track how CBD affects your specific IBS triggers. Many gastroenterologists now support CBD as a complementary tool alongside medication.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more